PROTEON THERAPEUTICS INC - COM (PRTO)

CUSIP: 74371L109

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
9,073,770
Share change
-54,791
Total reported value
$140,715,593
Price per share
$15.51
Number of holders
44
Value change
-$848,525
Number of buys
17
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 74371L109?
CUSIP 74371L109 identifies PRTO - PROTEON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTEON THERAPEUTICS INC - COM (PRTO) as of Q4 2015

As of 31 Dec 2015, PROTEON THERAPEUTICS INC - COM (PRTO) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,073,770 shares. The largest 10 holders included Abingworth LLP, RA CAPITAL MANAGEMENT, LLC, DEERFIELD MANAGEMENT CO, MPM ASSET MANAGEMENT LLC, FMR LLC, Deer VII & Co. Ltd., TIVERTON ASSET MANAGEMENT LLC, BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, and Omega Fund Management, LLC. This page lists 44 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.